Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A study has been conducted on the efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients. The research is part of a broader effort to address chronic viral infections, including HIV, with some studies focusing on vulnerabilities in the virus and potential treatments. However, it is unclear if this specific study has yielded a potential cure or breakthrough, as reports on its findings are not consistent with other recent developments in HIV research.
Full coverage
12345678